TNIP2 (TNFAIP3 Interacting Protein 2) functions as a crucial regulator of NF-κB signaling and inflammatory responses. The protein inhibits NF-κB activation by blocking RIPK1 interactions with downstream effector NEMO/IKBKG 1. TNIP2 demonstrates dual regulatory functions: it can both positively and negatively regulate NF-κB-dependent transcription depending on cellular context 2. The protein forms complexes with multiple signaling components and serves as a hub protein in the NF-κB network, interacting with transcription factors through its N-terminal region 2. Beyond inflammation, TNIP2 plays important roles in disease pathogenesis. In major depressive disorder, TNIP2 expression correlates with disease severity and mediates GRβ-promoted inflammation through the TNF-α pathway 3. The protein shows protective effects against endometritis by inhibiting NF-κB activation and reducing inflammatory cytokine production 1. TNIP2 also demonstrates anti-amyloidogenic properties by regulating BACE1 mRNA through 3'UTR binding, suggesting potential relevance in Alzheimer's disease 4. Clinically, TNIP2 has been identified as a candidate gene in rheumatoid arthritis through genome-wide association studies 5, and its expression is regulated by epigenetic modifications including histone methylation patterns associated with psychiatric disorders 6.